Antibodies to herpes‐type virus in nasopharyngeal carcinoma and control groups

Sera collected from patients with nasopharyngeal carcinoma (NPC), in Taiwan, were titrated for antibodies to herpes‐type virus (HTV) in a Burkitt's lymphoma cell line (P3HR‐1) by the indirect immunofluorescence antibody technique. The results were compared with those of neighborhood controls matched by age and sex, with patient families and with neighborhood control families. Antibody liters were higher in the NPC cases than in any of the 3 control groups. Dissociations in the frequency distributions of antibody titers in the NPC and healthy control groups were found to be maximum when the limiting value was set at 1:640. There were no significant differences in the frequency distribution among the 3 control groups. Of 117 NPC patients, 40% had anti‐HTV titers equal to or greater than 1:640, while such values occurred in only 5, 5, and 6%, respectively, of the neighborhood controls, patient families, and control families. Though not statistically significant, there was difference in the percentages of “sero‐positive” cases for the NPC patients by sex—42% for males and 35% for females. There was no sex difference, or it was a little higher in females, in the 3 control groups. The geometric mean titers were 1:242, 1:65, 1:69, and 1:61, respectively, for the NPC patients, neighborhood controls, patient families, and neighborhood control families. There was a difference in the geometric means by sex in the patients, i.e., 1:253 and 1:210, respectively, for males and females, while no differences by sex were noted in the 3 control groups. Ridit analysis and chi square test showed definitely different results between the NPC patients and the 3 control groups. The relative risks indicated that persons with antibody titer of 1:2560 had more than 200 times the NPC risk of those with antibody titer of less than 1:40. There were no indications of household aggregation of high anti‐HTV titer (≥ 1:640) in the patients and control families. The significance and implications of these findings are discussed.

[1]  C. Rizzi Statistical Methods , 2020, Springer Theses.

[2]  H. Sugano,et al.  Presence of Herpes-type Virus in the Culture Cell Line from a Nasopharyngeal Carcinoma in Taiwan , 1970 .

[3]  V. Diehl,et al.  Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, other head and neck neoplasms, and control groups. , 1970, Journal of the National Cancer Institute.

[4]  G. de‐Thé,et al.  Lymphoblastoid Transformation and Presence of Herpes-type Viral Particles in a Chinese Nasopharyngeal Tumour cultured in vitro , 1969, Nature.

[5]  P. Gerber,et al.  Infectious Mononucleosis: Complement-Fixing Antibodies to Herpes-Like Virus Associated with Burkitt Lymphoma , 1968, Science.

[6]  V. Diehl,et al.  Relation of Burkitt's tumor-associated herpes-ytpe virus to infectious mononucleosis. , 1968, Proceedings of the National Academy of Sciences of the United States of America.

[7]  M. Konn,et al.  Replication of Herpes-Type Virus in a Burkitt Lymphoma Cell Line , 1967, Journal of virology.

[8]  J. Burchenal,et al.  Membrane immunofluorescence reactions of Burkitt lymphoma cells from biopsy specimens and tissue cultures. , 1967, Journal of the National Cancer Institute.

[9]  M. Konn,et al.  Immunofluorescence and Herpes-Type Virus Particles in the P3HR-1 Burkitt Lymphoma Cell Line , 1967, Journal of virology.

[10]  Y. Hinuma,et al.  Cloning of Immunoglobulin-Producing Human Leukemic and Lymphoma Cells in Long-Term Cultures.∗ , 1967, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[11]  L. Old,et al.  PRECIPITATING ANTIBODY IN HUMAN SERUM TO AN ANTIGEN PRESENT IN CULTURED BURKITT'S LYMPHOMA CELLS* , 1966, Proceedings of the National Academy of Sciences of the United States of America.

[12]  G. Schidlovsky,et al.  Partial Purification and Electron Microscopy of Virus in the EB-3 Cell Line Derived from a Burkitt Lymphoma , 1966, Science.

[13]  W. Henle,et al.  Complement-Fixation Tests with Cell Lines Derived from Burkitt's Lymphoma and Acute Leukemias , 1966, Journal of bacteriology.

[14]  J. Whang,et al.  BURKITT TUMOR: TISSUE CULTURE, CYTOGENETIC AND VIRUS STUDIES. , 1965, Journal of the National Cancer Institute.

[15]  M. Epstein,et al.  VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA. , 1964, Lancet.

[16]  Nathan Mantel,et al.  Chi-square tests with one degree of freedom , 1963 .

[17]  G. Linden,et al.  Studies on Heredity and Environment in Cancer of the Nasopharynx , 1962 .

[18]  C. Hu,et al.  A decade of progress in morphologic pathology. , 1959, Chinese medical journal.

[19]  W. Haenszel,et al.  Statistical aspects of the analysis of data from retrospective studies of disease. , 1959, Journal of the National Cancer Institute.

[20]  I. Bross How to use Ridit Analysis , 1958 .